These findings suggest that a pathological derangement in pancreatic tissues already triggers the release of these two proteins into the bloodstream (in particular, LAMC2 in cystadenoma and pancreatitis, and PTX3 in IPMN), and that further diagnostic imaging is warranted. This evidence concerns the gene LAMC2 and pancreatic intraductal papillary-mucinous neoplasm.